Equities Analysts Issue Forecasts for LifeStance Health Group, Inc.'s Q1 2023 Earnings (NASDAQ:LFST)
Equities Analysts Issue Forecasts for LifeStance Health Group, Inc.'s Q1 2023 Earnings (NASDAQ:LFST)
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) – Research analysts at William Blair lowered their Q1 2023 earnings per share (EPS) estimates for LifeStance Health Group in a note issued to investors on Wednesday, February 1st. William Blair analyst R. Daniels now expects that the company will post earnings per share of ($0.13) for the quarter, down from their prior forecast of ($0.12). The consensus estimate for LifeStance Health Group's current full-year earnings is ($0.60) per share. William Blair also issued estimates for LifeStance Health Group's Q2 2023 earnings at ($0.12) EPS, Q3 2023 earnings at ($0.11) EPS, Q4 2023 earnings at ($0.10) EPS and FY2023 earnings at ($0.47) EPS.
LifeStance Health Group,Inc.(納斯達克代碼:LFST-GET Rating)-威廉·布萊爾的研究分析師在2月1日星期三發給投資者的一份報告中下調了對LifeStance Health Group 2023年第一季度每股收益(EPS)的預期。威廉·布萊爾分析師R.Daniels現在預計,該公司本季度每股收益將為0.13美元,低於此前預測的0.12美元。對LifeStance Health Group目前全年收益的普遍估計是每股0.60美元。威廉·布萊爾還發布了對LifeStance Health Group 2023年第二季度每股收益(0.12美元)、2023年第三季度每股收益(0.11美元)、2023年第四季度每股收益(0.10美元)和2023財年每股收益(0.47美元)的預期。
LifeStance Health Group (NASDAQ:LFST – Get Rating) last issued its quarterly earnings data on Tuesday, November 8th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $0.04. LifeStance Health Group had a negative return on equity of 18.01% and a negative net margin of 33.77%. The company had revenue of $217.56 million during the quarter, compared to the consensus estimate of $219.69 million.
LifeStance Health Group(納斯達克:LFST-GET評級)最近一次發佈季度收益數據是在11月8日(星期二)。該公司公佈本季度每股收益(EPS)為0.11美元,比分析師普遍預期的每股收益(0.15美元)高出0.04美元。LifeStance Health Group的淨資產回報率為負18.01%,淨利潤率為負33.77%。該公司本季度營收為2.1756億美元,而市場普遍預期為2.1969億美元。
LifeStance Health Group Price Performance
LifeStance Health Group價格表現
Shares of LFST opened at $5.53 on Monday. LifeStance Health Group has a 1 year low of $4.22 and a 1 year high of $11.25. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.25 and a quick ratio of 2.25. The company has a market capitalization of $2.08 billion, a price-to-earnings ratio of -6.91 and a beta of 0.61. The business has a 50-day moving average of $5.09 and a 200-day moving average of $6.37.
週一,LFST的股價開盤報5.53美元。LifeStance Health Group的一年低點為4.22美元,一年高位為11.25美元。該公司的債務權益比為0.14,流動比率為2.25,速動比率為2.25。該公司市值20.8億美元,市盈率為-6.91倍,貝塔係數為0.61。該業務的50日移動均線切入位在5.09美元,200日移動均線切入位在6.37美元。
Institutional Investors Weigh In On LifeStance Health Group
機構投資者看好LifeStance Health Group
Hedge funds and other institutional investors have recently modified their holdings of the company. OLD National Bancorp IN bought a new stake in shares of LifeStance Health Group during the fourth quarter valued at approximately $49,000. Dynamic Advisor Solutions LLC bought a new stake in shares of LifeStance Health Group during the fourth quarter valued at approximately $56,000. Ameritas Investment Partners Inc. increased its holdings in shares of LifeStance Health Group by 56.6% during the first quarter. Ameritas Investment Partners Inc. now owns 5,575 shares of the company's stock valued at $56,000 after acquiring an additional 2,016 shares in the last quarter. Point72 Hong Kong Ltd bought a new stake in shares of LifeStance Health Group during the second quarter valued at approximately $63,000. Finally, Price T Rowe Associates Inc. MD purchased a new position in shares of LifeStance Health Group during the third quarter valued at approximately $75,000. Institutional investors own 76.49% of the company's stock.
對衝基金和其他機構投資者最近調整了對該公司的持股。Old National Bancorp IN在第四季度購買了LifeStance Health Group的新股,價值約4.9萬美元。Dynamic Advisor Solutions LLC在第四季度購買了LifeStance Health Group的新股,價值約56,000美元。今年第一季度,ameritas Investment Partners Inc.增持的LifeStance Health Group股票增加了56.6%。Ameritas Investment Partners Inc.目前持有該公司5,575股股票,價值56,000美元,該公司在上個季度增持了2,016股股票。Point72 Hong Kong Ltd在第二季度購買了LifeStance Health Group的新股,價值約63,000美元。最後,Price T Rowe Associates Inc.MD在第三季度購買了LifeStance Health Group價值約7.5萬美元的新股票頭寸。機構投資者持有該公司76.49%的股份。
LifeStance Health Group Company Profile
LifeStance Health Group公司簡介
(Get Rating)
(獲取評級)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
LifeStance Health Group,Inc.通過其子公司提供門診精神健康服務。該公司為患者提供一整套精神健康服務,包括精神評估和治療、心理和神經心理測試,以及個人、家庭和團體治療。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on LifeStance Health Group (LFST)
- MarketBeat Week in Review – 1/30 – 2/3
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
- 免費獲取StockNews.com關於LifeStance Health Group(LFST)的研究報告
- 市場回顧周-1/30-2/3
- 細價股值得嗎?你應該投資細價股嗎?
- Zimmer Biomet盈利節節攀升,增長可能被計入價格
- 人工智能軟件製造商EPAM號稱科技板塊漲幅最大
- 福特股票在盈利大幅下滑後繼續前進
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
接受LifeStance健康集團日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收LifeStance Health Group和相關公司的最新新聞和分析師評級的每日摘要。